Fibrosis in Pathology of Heart and Kidney: From Deep RNA-Sequencing to Novel Molecular Targets

Area of Science:

• Cardiovascular and Renal Medicine
• Molecular Pathology
• Genomics

Background:

• Heart and kidney diseases significantly reduce patient life expectancy and quality of life.
• The heart and kidney are functionally interconnected, meaning dysfunction in one organ impacts the other.
• Fibrosis is a common pathological endpoint for various heart and kidney diseases, making its inhibition a potential therapeutic target.

Purpose of the Study:

• To review the evolution of RNA-sequencing techniques for investigating disease mechanisms.
• To summarize current understanding of heart and kidney fibrosis pathogenesis.
• To explore the utility of transcriptomic data in identifying novel drug targets and therapeutic strategies for fibrotic diseases.

Main Methods:

• Review of existing literature on RNA-sequencing technologies and their application in fibrosis research.
• Analysis of recent findings on the molecular pathogenesis of cardiac and renal fibrosis.
• Discussion of transcriptomic data analysis for drug discovery.

Main Results:

• Single-cell RNA sequencing has advanced the molecular-level investigation of disease pathomechanisms.
• RNA sequencing facilitates the identification of disease-associated cell types and molecular mechanisms driving fibrosis.
• Transcriptomic insights offer potential for developing targeted antifibrotic therapies.

Conclusions:

• Understanding the molecular drivers of fibrosis is crucial for treating heart and kidney diseases.
• RNA sequencing provides powerful tools to elucidate complex fibrotic processes.
• Transcriptomic data analysis holds promise for the development of innovative therapeutic strategies against heart and kidney fibrosis.